Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2831 of 5804
-
Scientists hunt for harmful immune cells in MS patients
Knowledge-focused Recruiting nowThe study aims at identifying the type of B and CD4 T cell subsets with pathogenic properties in the different clinical forms of multiple sclerosis. This research might open new therapeutic approaches for the treatment of multiple sclerosis particularly progressive MS.
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Testosterone Therapy's heart risks under the microscope for transgender youth
Knowledge-focused OngoingTransgender individuals are those with a gender identity opposite the sex they were assigned at birth. Approximately 1% of the population is transgender, equating to \~60,000 transgender Wisconsinites. A transgender boy or man is someone with a 46,XX karyotype and typical female …
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New study tracks lung function in pregnant women with cystic fibrosis
Knowledge-focused OngoingIn this study, the investigators aim to evaluate changes in lung function in women with cystic fibrosis (CF) during pregnancy and for 2 years after pregnancy based on exposure to highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
Sponsor: Amalia Magaret • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Massive medicaid study pinpoints when stimulant overdose strikes
Knowledge-focused CompletedThis project addresses Objective 2 of RFA-CE-21-002: to assess risk and protective factors for illicit stimulant use, use disorder, or overdose that can contribute to the development or adaptation of intervention strategies. The study will 1) develop and validate a model using bo…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Experimental drug targets Notch-Activated cancer before surgery
Disease control CompletedThis phase Ib trial studies the side effects and possible benefits of AL101 before surgery in treating patients with notch activated adenoid cystic cancer. AL101 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving AL101 before surgery…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a mitral valve fix a tricuspid problem? small trial tests donor tissue swap
Disease control OngoingThe aim of the study is to evaluate early safety and clinical efficacy of mitral allografts in tricuspid valve replacement for primary tricuspid valve diseases.
Sponsor: Chelyabinsk Regional Clinical Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Mammograms may reveal hidden heart risks – new study tests if telling women saves lives
Knowledge-focused OngoingThe purpose of this research study was to determine the potential benefits of adding information on patients' breast arterial calcification (BAC) results to the standard results letter women receive after mammography. In addition to looking for potential breast cancer, research s…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Iron showdown: IV vs pills for anemia in pregnancy
Disease control Recruiting nowThis is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, q…
Phase: PHASE4 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New Pig-Tissue patch shows promise for fixing eardrums
Disease control CompletedThe post-market follow-up clinical trial of the Cook® Biodesign® Otologic Repair Graft will follow patients up to 3 months post-implantation to determine the percent of patients with complete closure of the tympanic membrane.
Sponsor: Cook Research Incorporated • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Immune cell analysis could unlock ALS mysteries
Knowledge-focused Recruiting nowThe aim of this project is to analyze the macrophage transcriptome and protein markers of Amyotrophic Lateral Sclerosis (ALS) patients compared to controls (non-affected individuals, patients with other motor impairments) and asymptomatic ALS gene carriers, to find new pathways f…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Deep clean teeth to tame heart disease and diabetes?
Disease control CompletedPurpose: The Baseline Oral Health Health Study is a randomized controlled trial to evaluate the impact of regular, professional non-surgical Intensive Periodontal Therapy (scaling and root planing and optimal oral hygiene with associated professional oral health behavior advice )…
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy targets Hard-to-Treat esophageal cancer
Disease control CompletedAn open label single arm phase II trial in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma which is MGMT deficient.
Phase: PHASE2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Experimental drug combo takes aim at relapsed leukemia
Disease control OngoingThis phase I trial is to find out the best dose and side effects of tegavivint in treating patients with leukemia that has come back (relapsed) or does not response to treatment (refractory). Tegavivint may stop the growth of cancer cells by blocking some of the enzymes needed fo…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Hypnosis may offer Drug-Free relief for COPD anxiety and breathlessness
Symptom relief CompletedPatients with chronic obstructive pulmonary disease (COPD) are prone to breathlessness, chest tightness and other anxiety-inducing symptoms. Medical therapy for the condition focus on improving these symptoms and preventing exacerbations. However, as the disease progresses, pharm…
Phase: NA • Sponsor: Centre Hospitalier de Bligny • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New therapy shows promise for troubled youth
Symptom relief OngoingThe study will compare the impact FIRST (a transdiagnostic treatment built upon five empirically supported principles of change) versus usual care outpatient psychotherapy on youths' mental health outcomes and a candidate mechanism of change: regulation of negative emotions.
Phase: NA • Sponsor: Harvard University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Phone app could ease distress in breast cancer survivors
Symptom relief CompletedThe overarching goals of this project are to provide the first rigorous test of a scalable and publicly accessible mobile health intervention (IntelliCare) to address emotional distress in women with breast cancer, and to test the impact of human coaching as a way to increase eng…
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Texts and trackers: new study aims to get young cancer survivors moving
Symptom relief OngoingIn this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a…
Phase: NA • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Kidney transplant study tests vaccine booster strategy
Knowledge-focused OngoingImmunocompromised individuals, such as solid organ transplant (SOT) recipients are at high risk of COVID-19 associated complications and mortality. Retrospective studies so far have shown that a majority of SOT recipients did not develop appreciable anti-spike antibody response a…
Phase: PHASE4 • Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Iron infusion may speed recovery after heart surgery in seniors
Disease control Recruiting nowPostoperative anemia is common in cardiac surgery with cardiopulmonary bypass. Iron deficiency delays the recovery from postoperative anemia and may negatively affect the postoperative trajectory of cardiac surgery patients. The objective of the study is to determine the effect o…
Phase: PHASE4 • Sponsor: dr. P. Noordzij • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Experimental lung cancer combo trial ends early
Disease control TerminatedThe Primary Objective was: -To determine the antitumor activity of SAR444245 in combination with other anticancer therapies. The Secondary Objectives were: * To confirm the dose and to assess the safety profile of SAR444245 when combined with other anticancer therapies. * To a…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC